Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Namdar

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Studies in Health Technology and Informatics|May 25, 2022
A Lightweight and Interpretable Model to Classify Bundle Branch Blocks from ECG SignalsHugues Turbé, Mina Bjelogrlic, Mehdi Namdar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segmentsPascal Koepfli, Christophe A Wyss, Mehdi Namdar, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 30, 2004
Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomyManuela Jörg-Ciopor, Mehdi Namdar, Jurai Turina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2004
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemiaChristophe A Wyss, Pascal Koepfli, Mehdi Namdar, et al.
Frontiers in Cardiovascular Medicine|February 5, 2025
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase BetaGavin Y Oudit, Pronabesh DasMahapatra, Nicole Lyn, et al.
Journal of Inherited Metabolic Disease|October 12, 2012
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseMarkus Niemann, Tanja Hartmann, Mehdi Namdar, et al.
Plos One|May 5, 2012
Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry diseaseMehdi Namdar, Catherine Gebhard, Rafael Studiger, et al.
Cardiology Journal|August 31, 2013
Comprehensive cardiac resynchronization therapy optimization in the real worldJan Steffel, Helene Rempel, Alexander Breitenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2007
Absolute quantification of myocardial blood flow with 13N-ammonia and 3-dimensional PETTiziano Schepis, Oliver Gaemperli, Valerie Treyer, et al.
Heart (British Cardiac Society)|May 15, 2024
Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapyNiccolo Maurizi, Albina Nowak, Christiane Gruner, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Studies in Health Technology and Informatics|May 25, 2022
A Lightweight and Interpretable Model to Classify Bundle Branch Blocks from ECG SignalsHugues Turbé, Mina Bjelogrlic, Mehdi Namdar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segmentsPascal Koepfli, Christophe A Wyss, Mehdi Namdar, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 30, 2004
Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomyManuela Jörg-Ciopor, Mehdi Namdar, Jurai Turina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 4, 2004
Tetrahydrobiopterin restores impaired coronary microvascular dysfunction in hypercholesterolaemiaChristophe A Wyss, Pascal Koepfli, Mehdi Namdar, et al.
Frontiers in Cardiovascular Medicine|February 5, 2025
A systematic literature review to evaluate the cardiac and cerebrovascular outcomes of patients with Fabry disease treated with agalsidase BetaGavin Y Oudit, Pronabesh DasMahapatra, Nicole Lyn, et al.
Journal of Inherited Metabolic Disease|October 12, 2012
Cross-sectional baseline analysis of electrocardiography in a large cohort of patients with untreated Fabry diseaseMarkus Niemann, Tanja Hartmann, Mehdi Namdar, et al.
Plos One|May 5, 2012
Globotriaosylsphingosine accumulation and not alpha-galactosidase-A deficiency causes endothelial dysfunction in Fabry diseaseMehdi Namdar, Catherine Gebhard, Rafael Studiger, et al.
Cardiology Journal|August 31, 2013
Comprehensive cardiac resynchronization therapy optimization in the real worldJan Steffel, Helene Rempel, Alexander Breitenstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2007
Absolute quantification of myocardial blood flow with 13N-ammonia and 3-dimensional PETTiziano Schepis, Oliver Gaemperli, Valerie Treyer, et al.
Heart (British Cardiac Society)|May 15, 2024
Fabry disease: development and progression of left ventricular hypertrophy despite long-term enzyme replacement therapyNiccolo Maurizi, Albina Nowak, Christiane Gruner, et al.
Pageof 11